Insider Trading activities of Novabay Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Novabay Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Novabay Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Novabay Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is NBY. The reporting company's CIK number is 1389545.
The total value of stock buying since 2005 is $25,766,163.
The total value of stock sales since 2005 is $331,599.
The total value of stock option exercises since 2005 is $191,999.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Novabay Pharmaceuticals, Inc. (NBY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-08 12,000 $5,640 0 $0 0 $0
2015-03 2,923,332 $1,753,998 0 $0 0 $0
2014-12 143,000 $93,630 30,000 $20,899 0 $0
2014-06 4,800 $4,272 0 $0 0 $0
2014-05 525,000 $516,998 0 $0 0 $0
2014-04 0 $0 0 $0 52,000 $29,120
2014-03 0 $0 0 $0 9,000 $5,040
2013-12 15,000,000 $17,099,997 0 $0 0 $0
2013-11 108,156 $110,319 0 $0 0 $0
2013-09 0 $0 120,000 $225,000 0 $0
2012-12 160,000 $193,600 0 $0 0 $0
2012-10 3,600,000 $4,500,000 0 $0 0 $0
2012-09 800,000 $1,000,000 0 $0 28,500 $15,960
2012-05 19,500 $18,585 0 $0 0 $0
2011-09 3,000 $2,520 0 $0 0 $0
2011-08 18,500 $15,750 0 $0 0 $0
2011-05 11,252 $18,571 0 $0 0 $0
2010-08 0 $0 15,000 $27,450 0 $0
2010-01 0 $0 0 $0 18,158 $36,679
2009-09 0 $0 0 $0 10,000 $5,600
2009-08 1,000 $1,900 0 $0 20,000 $11,200
2009-06 25,000 $58,250 25,000 $58,250 0 $0
2008-12 500 $570 0 $0 0 $0
2008-09 5,200 $10,073 0 $0 0 $0
2008-08 3,600 $7,132 0 $0 0 $0
2008-04 0 $0 0 $0 52,000 $88,400
2008-03 31,300 $84,358 0 $0 0 $0
2007-10 67,500 $270,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Novabay Pharmaceuticals, Inc. insiders (NBY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-08-20 Najafi Ramin (Chief Executive Officer) Buy 6,000 .44 2,640
2015-08-19 Najafi Ramin (Chief Executive Officer) Buy 6,000 .50 3,000
2015-03-03 Pioneer Pharma (singapore) Pte. Ltd. (10% Owner) Buy 2,590,000 .60 1,554,000
2015-03-03 Najafi Ramin (Chief Executive Officer) Buy 166,666 .60 99,999
2015-03-03 Sieczkarek Mark M (Director) Buy 166,666 .60 99,999
2014-12-12 Stroman David W. (SVP, Ophthalmic Product Devt.) Buy 10,000 .66 6,600
2014-12-12 Najafi Ramin (Chief Executive Officer) Buy 50,000 .65 32,500
2014-12-12 Paulson Thomas J (CFO) Buy 10,000 .68 6,800
2014-12-11 Najafi Ramin (Chief Executive Officer) Buy 20,000 .60 12,000
2014-12-09 Paulson Thomas J (CFO) Buy 10,000 .67 6,700
2014-12-05 Najafi Ramin (Chief Executive Officer) Buy 25,000 .65 16,250
2014-12-02 Najafi Ramin (Chief Executive Officer) Buy 18,000 .71 12,780
2014-12-02 Wicks Tony D.s. (Director) Sale 20,000 .70 14,000
2014-12-01 Wicks Tony D.s. (Director) Sale 10,000 .69 6,899
2014-06-04 Sieczkarek Mark M (Director) Buy 4,800 .89 4,272
2014-05-19 Sieczkarek Mark M (Director) Buy 25,000 .88 22,000
2014-05-13 China Pioneer Pharma Holdings Ltd (10% Owner) Buy 65,065 .99 64,414
2014-05-12 China Pioneer Pharma Holdings Ltd (10% Owner) Buy 116,107 .99 114,945
2014-05-09 China Pioneer Pharma Holdings Ltd (10% Owner) Buy 318,828 .99 315,639
2014-04-14 Wicks Tony D.s. (Director) Option Ex 52,000 .56 29,120
2014-03-17 Dailley Anthony (Director) Option Ex 9,000 .56 5,040
2013-12-02 Pioneer Pharma (hong Kong) Co Ltd (10% Owner) Buy 5,000,000 1.14 5,699,999
2013-12-02 China Pioneer Pharma Holdings Ltd (10% Owner) Buy 5,000,000 1.14 5,699,999
2013-12-02 Pioneer Pharma (singapore) Pte. Ltd. (10% Owner) Buy 5,000,000 1.14 5,699,999
2013-11-14 China Pioneer Pharma Holdings Ltd (10% Owner) Buy 108,156 1.02 110,319
2013-09-20 Li Xinzhou (10% Owner) Sale 120,000 1.88 225,000
2012-12-11 Li Xinzhou (Other) Buy 120,000 1.20 144,000
2012-12-06 Stroman David W. (SVP, Ophthalmic Product Devt.) Buy 10,000 1.24 12,400
2012-12-06 Najafi Ramin (Chief Executive Officer) Buy 20,000 1.24 24,800
2012-12-06 Paulson Thomas J (CFO) Buy 10,000 1.24 12,400
2012-10-31 Li Xinzhou (10% Owner) Buy 1,200,000 1.25 1,500,000
2012-10-31 Naqu Area Pioneer Pharma Co., Ltd. (10% Owner) Buy 1,200,000 1.25 1,500,000
2012-10-31 Pioneer Pharma (singapore) Pte. Ltd. (10% Owner) Buy 1,200,000 1.25 1,500,000
2012-09-27 Tufts Robert R. (Director) Option Ex 28,500 .56 15,960
2012-09-13 Li Xinzhou (10% Owner) Buy 800,000 1.25 1,000,000
2012-05-30 Paulson Thomas J (CFO) Buy 10,000 .94 9,360
2012-05-29 Najafi Ramin (Chief Executive Officer) Buy 6,000 .96 5,760
2012-05-25 Najafi Ramin (Chief Executive Officer) Buy 3,500 .99 3,465
2011-09-12 Freiman Paul E. (Director) Buy 3,000 .84 2,520
2011-08-26 Paulson Thomas J (CFO) Buy 3,500 .86 3,010
2011-08-16 Najafi Family Trust Dated September 13, 2006 (Other) Buy 10,000 .85 8,500
2011-08-15 Tufts Robert R. (Director) Buy 5,000 .85 4,240
2011-05-27 Mcpherson T. Alex (Director) Buy 6,200 1.64 10,174
2011-05-27 Najafi Ramin (Chief Executive Officer) Buy 500 1.60 797
2011-05-27 Khosrovi Behzad (VP Research and Development) Buy 1,000 1.64 1,640
2011-05-26 Najafi Ramin (Chief Executive Officer) Buy 1,000 1.60 1,597
2011-05-24 Najafi Ramin (Chief Executive Officer) Buy 2,552 1.71 4,363
2010-08-16 Freiman Paul E. Sale 15,000 1.83 27,450
2010-01-04 Tufts Robert R. Option Ex 18,158 2.02 36,679
2009-09-03 Dailley Anthony Option Ex 10,000 .56 5,600
2009-08-31 Cashion Charles Buy 1,000 1.90 1,900
2009-08-31 Tufts Robert R. Option Ex 20,000 .56 11,200
2009-06-11 Freiman Paul E. Sale 25,000 2.33 58,250
2009-06-11 Hixson Harry F Jr Buy 25,000 2.33 58,250
2008-12-10 Najafi Family Trust Dated September 13, 2006 Buy 500 1.14 570
2008-09-12 Mcpherson T. Alex (Director) Buy 200 2.00 400
2008-09-12 Najafi Family Trust Dated September 13, 2006 Buy 500 1.90 948
2008-09-12 Paulson Thomas J (CFO) Buy 1,900 1.94 3,676
2008-09-11 Najafi Family Trust Dated September 13, 2006 Buy 1,000 1.92 1,924
2008-09-11 Khosrovi Behzad (VP Research and Development) Buy 500 1.95 975
2008-09-11 Paulson Thomas J (CFO) Buy 100 1.70 170
2008-09-02 Najafi Family Trust Dated September 13, 2006 Buy 1,000 1.98 1,980
2008-08-28 Najafi Family Trust Dated September 13, 2006 Buy 1,000 1.92 1,920
2008-08-20 Najafi Family Trust Dated September 13, 2006 (10% Owner) Buy 600 1.97 1,182
2008-08-19 Najafi Family Trust Dated September 13, 2006 (10% Owner) Buy 2,000 2.02 4,030
2008-04-22 Tufts Robert R. (Director) Option Ex 52,000 1.70 88,400
2008-03-14 Mcpherson T. Alex (Director) Buy 1,000 2.97 2,970
2008-03-14 Najafi Family Trust Dated September 13, 2006 (10% Owner) Buy 7,200 2.67 19,244
2008-03-14 Khosrovi Behzad (VP, Research & Dev't) Buy 1,000 2.72 2,720
2008-03-14 Dailley Anthony (Director) Buy 6,000 2.75 16,500
2008-03-14 Paulson Thomas J (Chief Financial Officer) Buy 4,000 2.70 10,800
2008-03-13 Tufts Robert R. (Director) Buy 2,500 2.40 6,007
2007-10-31 Tufts Robert R. (Director) Buy 67,500 4.00 270,000

Insider trading activities including stock purchases, stock sales, and option exercises of NBY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Novabay Pharmaceuticals, Inc. (symbol NBY, CIK number 1389545) see the Securities and Exchange Commission (SEC) website.